Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry
|
May 16, 2007
Modulating paclitaxel bioavailability for targeting prostate cancer
Srinivas K Kumar, Simon A Williams, John T Isaacs, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 13, 2013
Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma
Michael L Manning, Simon A Williams, Christine A Jelinek, et al.
The Prostate
|
June 9, 2016
Mutational Analysis of Prostate-Specific Antigen Defines the Intrinsic Proteolytic Activity of the proPSA Zymogen
Niquiche Sangster-Guity, Becky Tu-Sekine, Daniel M Raben, et al.
The Prostate
|
March 12, 2011
Enzymatically active prostate-specific antigen promotes growth of human prostate cancers
Simon A Williams, Christine A Jelinek, Ivan Litvinov, et al.
Cancer Research
|
June 3, 2005
Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells
Laura M Lashinger, Keyi Zhu, Simon A Williams, et al.
Journal of the National Cancer Institute
|
March 8, 2007
A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease
Simon A Williams, Rosemina F Merchant, Elizabeth Garrett-Mayer, et al.
Proteins
|
September 27, 2007
Mechanistic insights into the inhibition of prostate specific antigen by beta-lactam class compounds
Pratap Singh, Simon A Williams, Meha H Shah, et al.
Anti-Cancer Drugs
|
June 22, 2007
Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity
Ravibhushan Singh, Jeff L Browning, Ralph Abi-Habib, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry
|
May 16, 2007
Modulating paclitaxel bioavailability for targeting prostate cancer
Srinivas K Kumar, Simon A Williams, John T Isaacs, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 13, 2013
Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma
Michael L Manning, Simon A Williams, Christine A Jelinek, et al.
The Prostate
|
June 9, 2016
Mutational Analysis of Prostate-Specific Antigen Defines the Intrinsic Proteolytic Activity of the proPSA Zymogen
Niquiche Sangster-Guity, Becky Tu-Sekine, Daniel M Raben, et al.
The Prostate
|
March 12, 2011
Enzymatically active prostate-specific antigen promotes growth of human prostate cancers
Simon A Williams, Christine A Jelinek, Ivan Litvinov, et al.
Cancer Research
|
June 3, 2005
Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells
Laura M Lashinger, Keyi Zhu, Simon A Williams, et al.
Journal of the National Cancer Institute
|
March 8, 2007
A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease
Simon A Williams, Rosemina F Merchant, Elizabeth Garrett-Mayer, et al.
Proteins
|
September 27, 2007
Mechanistic insights into the inhibition of prostate specific antigen by beta-lactam class compounds
Pratap Singh, Simon A Williams, Meha H Shah, et al.
Anti-Cancer Drugs
|
June 22, 2007
Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity
Ravibhushan Singh, Jeff L Browning, Ralph Abi-Habib, et al.
Page
of 2